Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Tiziana Life SciencesAtossa TherapeuticsEton PharmaceuticalsInfinity PharmaceuticalsFS Development
SymbolNASDAQ:TLSANASDAQ:ATOSNASDAQ:ETONNASDAQ:INFINASDAQ:FSDC
Price Information
Current Price$2.57$1.86$7.57$3.12$11.54
52 Week RangeBuyBuyBuyBuyN/A
MarketRank™
Overall Score1.21.21.31.60.3
Analysis Score3.53.53.54.40.0
Community Score2.32.52.42.00.0
Dividend Score0.00.00.00.00.0
Ownership Score0.00.00.00.81.7
Earnings & Valuation Score0.00.00.60.60.0
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyN/A
Consensus Price Target$9.50$7.50$12.00$9.00N/A
% Upside from Price Target269.65% upside303.23% upside58.52% upside188.46% upsideN/A
Trade Information
Market Cap$165.05 million$224.73 million$184.77 million$276.56 million$144.44 million
Beta1.412.341.292.4N/A
Average Volume1,071,06222,215,777168,5273,725,202332,704
Sales & Book Value
Annual RevenueN/AN/A$460,000.00$3.05 millionN/A
Price / SalesN/AN/A401.6790.67N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value($0.09) per share$1.37 per share$0.59 per share$0.14 per shareN/A
Price / BookN/AN/A12.8322.29N/A
Profitability
Net Income$-9,320,000.00$-17,240,000.00$-18,320,000.00$-47,060,000.00N/A
EPS($0.03)N/A($1.03)($0.83)N/A
Trailing P/E RatioN/AN/AN/AN/A0.00
Forward P/E RatioN/A∞N/AN/A∞
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/A-2,592.65%N/A
Return on Equity (ROE)N/A-130.58%-310.64%-1,358.77%N/A
Return on Assets (ROA)N/A-108.14%-152.51%-81.85%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A4.89%N/AN/A
Current Ratio1.86%7.23%3.04%4.42%2.91%
Quick RatioN/A7.23%2.51%4.42%2.91%
Ownership Information
Institutional Ownership PercentageN/A6.87%29.06%46.66%89.82%
Insider Ownership PercentageN/A33.21%12.92%13.77%N/A
Miscellaneous
Employees841725N/A
Shares Outstanding64.22 million120.82 million24.41 million88.64 million12.52 million
Next Earnings Date6/16/2021 (Estimated)5/12/2021 (Estimated)5/13/2021 (Estimated)5/10/2021 (Estimated)N/A
OptionableNot OptionableNot OptionableNot OptionableOptionableNot Optionable
SourceHeadline
Hong Kong, Morocco groups to collaborate on financial servicesHong Kong, Morocco groups to collaborate on financial services
asiaasset.com - March 11 at 2:36 PM
Foresite Capitals second SPAC FS Development II raises deal size by 50% ahead of $150 million IPOForesite Capital's second SPAC FS Development II raises deal size by 50% ahead of $150 million IPO
nasdaq.com - February 9 at 5:55 PM
Hong Kong asks departing finance executives to explain themselvesHong Kong asks departing finance executives to explain themselves
ft.com - January 27 at 7:44 AM
Foresite Capitals second SPAC FS Development II files for a $100 million IPOForesite Capital's second SPAC FS Development II files for a $100 million IPO
nasdaq.com - January 26 at 7:51 PM
FS Development Corp. Announces Effectiveness of Registration Statement for Proposed Business Combination with Gemini Special Meeting Scheduled for FebFS Development Corp. Announces Effectiveness of Registration Statement for Proposed Business Combination with Gemini Special Meeting Scheduled for Feb
us.acrofan.com - January 21 at 11:51 PM
FS Development Corp. Announces Effectiveness of Registration Statement for Proposed Business Combination with Gemini Special Meeting Scheduled for February 3, 2021FS Development Corp. Announces Effectiveness of Registration Statement for Proposed Business Combination with Gemini Special Meeting Scheduled for February 3, 2021
businesswire.com - January 20 at 5:09 AM
FSDC of RBI reviews matters related to insolvency resolution, KYC data utilisation & Alternative Investment FundsFSDC of RBI reviews matters related to insolvency resolution, KYC data utilisation & Alternative Investment Funds
knnindia.co.in - January 14 at 6:23 PM
RBI Financial Stability And Development Council Discusses Scope For Improvements In Insolvency Resolution Under IBCRBI Financial Stability And Development Council Discusses Scope For Improvements In Insolvency Resolution Under IBC
business-standard.com - January 14 at 5:21 AM
RBI Governor headed FSDC sub-committee reviews developments in economyRBI Governor headed FSDC sub-committee reviews developments in economy
moneycontrol.com - January 13 at 1:38 PM
Shaktikanta Das headed FSDC sub-committee reviews developments in the economyShaktikanta Das headed FSDC sub-committee reviews developments in the economy
livemint.com - January 13 at 1:38 PM
RBI’s FSDC panel reviews insolvency resolution under IBCRBI’s FSDC panel reviews insolvency resolution under IBC
thehindubusinessline.com - January 13 at 1:38 PM
Financial Stability Council Sub-Committee Reviews State Of EconomyFinancial Stability Council Sub-Committee Reviews State Of Economy
bloombergquint.com - January 13 at 1:38 PM
FSDC sub-committee reviews developments in economyFSDC sub-committee reviews developments in economy
economictimes.indiatimes.com - January 13 at 1:38 PM
A special panel of FSDC considers changes in AIF regulationsA special panel of FSDC considers changes in AIF regulations
economictimes.indiatimes.com - January 13 at 1:38 PM
Sustainable opportunities for corporations in Hong Kong and around the worldSustainable opportunities for corporations in Hong Kong and around the world
bloomberg.com - January 11 at 2:50 PM
RBI governor asserts financial inclusion poised to grow in India with digital-savvy millennials joining workforceRBI governor asserts financial inclusion poised to grow in India with digital-savvy millennials joining workforce
news.webindia123.com - December 16 at 9:22 AM
Budget 2021 | FSDC deliberates on measures to accelerate growth momentumBudget 2021 | FSDC deliberates on measures to accelerate growth momentum
thehindu.com - December 15 at 7:03 PM
Economic recovery will be faster than predicted: FSDCEconomic recovery will be faster than predicted: FSDC
thehindubusinessline.com - December 15 at 2:00 PM
Financial Stability and Development Council takes stock of economy, financial sectorFinancial Stability and Development Council takes stock of economy, financial sector
economictimes.indiatimes.com - December 15 at 9:00 AM
On the parasitic Gupta family & other matters - SACPOn the parasitic Gupta family & other matters - SACP
politicsweb.co.za - December 12 at 7:45 PM
FS Development Corp. Class A Common Stock (FSDC)FS Development Corp. Class A Common Stock (FSDC)
nasdaq.com - October 16 at 7:07 PM
FS Development join forces with Gemini Therapeutics; combined company to be listed on NasdaqFS Development join forces with Gemini Therapeutics; combined company to be listed on Nasdaq
seekingalpha.com - October 15 at 8:35 AM
DateCompanyBrokerageAction
12/22/2020Tiziana Life SciencesB. RileyInitiated Coverage
9/21/2020Tiziana Life SciencesHC WainwrightReiterated Rating
9/10/2019Tiziana Life SciencesLaidlawSet Price Target
9/18/2020Atossa TherapeuticsMaxim GroupReiterated Rating
9/17/2020Atossa TherapeuticsAscendiant Capital MarketsInitiated Coverage
5/15/2018Atossa TherapeuticsNoble FinancialSet Price Target
8/5/2019Eton PharmaceuticalsLake Street CapitalInitiated Coverage
3/24/2021Infinity PharmaceuticalsTruist SecuritiesInitiated Coverage
3/23/2021Infinity PharmaceuticalsWells Fargo & CompanyBoost Price Target
3/18/2021Infinity PharmaceuticalsTruist FinancialInitiated Coverage
2/25/2021Infinity PharmaceuticalsPiper SandlerInitiated Coverage
2/11/2021Infinity PharmaceuticalsOppenheimerBoost Price Target
2/5/2021Infinity PharmaceuticalsJPMorgan Chase & Co.Upgrade
6/27/2019Infinity PharmaceuticalsCIBCInitiated Coverage
1/7/2019Infinity PharmaceuticalsUBS GroupReiterated Rating
(Data available from 4/14/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
Comparison Ideas:

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.